A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Recruiting · Phase 2 · NCT06798012
Conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
At a glance
- Research payments reported, 2025
- $168,272
- U.S. investigators named
- 6
- Sites paid
- 6
- Planned or actual enrollment
- 36
About the trial
- Sponsor
- Takeda
- Tested
- TAK-411 (biological)
- Dates
- Started 2025-05-14; completion 2028-06-08
- Results posted
- Not yet
CIDP is an autoimmune disease. This means that the body's germ fighting (immune) system attacks itself. In CIDP, the immune system attacks the protective covering around the nerves called myelin. Over time, these nerves lose their ability to send signals to the muscles in the body. This leads to muscle weakness and loss of sensation in arms and legs among other symptoms. Participants with CIDP can be treated with a protein called immunoglobulin (or IG). TAK-411 is a special type of immune globulin G (hsIgG) that has been chemically changed. It is made from IG that comes from human plasma. This study will test if TAK-411 can decrease inflammation and improve symptoms of CIDP. The main aim …
From ClinicalTrials.gov, last updated 2026-11-03. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Takeda Pharmaceuticals U.S.A., Inc. reported $168,272 in research payments for this study in 2025 (44 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Andrew M. Lerman, M.D. Neurology · Miami, FL
- Kathleen A. Murray, M.D. Neurology · Tampa, FL
- Christina N. Fournier, M.D. Neurology · Atlanta, GA
- Marcus Vinicius R. Pinto, MD Neurology · Rochester, MN
- William D. Arnold, M.D. Physical Medicine & Rehabilitation (PM&R) · Columbia, MO
- Dominic A. Ferrey I, M.D. Neurology · Columbus, OH
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- University of California Davis Medical Center, CA $70,225
- Mayo Clinic Hospital Rochester, MN $33,160
- Visionary Investigators Network $27,943
- University of South Florida $24,520
- University of Missouri Health Care, MO $10,840
- Emory University Hospital, GA $1,584
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.